239 related articles for article (PubMed ID: 14651780)
1. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
Platis D; Foster GR
J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
[TBL] [Abstract][Full Text] [Related]
2. Differences in activity between alpha and beta type I interferons explored by mutational analysis.
Runkel L; Pfeffer L; Lewerenz M; Monneron D; Yang CH; Murti A; Pellegrini S; Goelz S; Uzé G; Mogensen K
J Biol Chem; 1998 Apr; 273(14):8003-8. PubMed ID: 9525899
[TBL] [Abstract][Full Text] [Related]
3. Shared receptor components but distinct complexes for alpha and beta interferons.
Lewerenz M; Mogensen KE; Uzé G
J Mol Biol; 1998 Sep; 282(3):585-99. PubMed ID: 9737924
[TBL] [Abstract][Full Text] [Related]
4. Domains of interaction between alpha interferon and its receptor components.
Uzé G; Di Marco S; Mouchel-Vielh E; Monneron D; Bandu MT; Horisberger MA; Dorques A; Lutfalla G; Mogensen KE
J Mol Biol; 1994 Oct; 243(2):245-57. PubMed ID: 7932753
[TBL] [Abstract][Full Text] [Related]
5. Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase.
Rani MR; Leaman DW; Han Y; Leung S; Croze E; Fish EN; Wolfman A; Ransohoff RM
J Biol Chem; 1999 Nov; 274(45):32507-11. PubMed ID: 10542297
[TBL] [Abstract][Full Text] [Related]
6. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
Cutrone EC; Langer JA
J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
[TBL] [Abstract][Full Text] [Related]
7. N-glycosylation of murine IFN-beta in a putative receptor-binding region.
Sommereyns C; Michiels T
J Interferon Cytokine Res; 2006 Jun; 26(6):406-13. PubMed ID: 16734561
[TBL] [Abstract][Full Text] [Related]
8. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.
Abramovich C; Shulman LM; Ratovitski E; Harroch S; Tovey M; Eid P; Revel M
EMBO J; 1994 Dec; 13(24):5871-7. PubMed ID: 7813427
[TBL] [Abstract][Full Text] [Related]
9. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
[TBL] [Abstract][Full Text] [Related]
10. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.
Gauzzi MC; Barbieri G; Richter MF; Uzé G; Ling L; Fellous M; Pellegrini S
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11839-44. PubMed ID: 9342324
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists.
Pan M; Kalie E; Scaglione BJ; Raveche ES; Schreiber G; Langer JA
Biochemistry; 2008 Nov; 47(46):12018-27. PubMed ID: 18937499
[TBL] [Abstract][Full Text] [Related]
12. Homology model of human interferon-alpha 8 and its receptor complex.
Seto MH; Harkins RN; Adler M; Whitlow M; Church WB; Croze E
Protein Sci; 1995 Apr; 4(4):655-70. PubMed ID: 7613464
[TBL] [Abstract][Full Text] [Related]
13. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
[TBL] [Abstract][Full Text] [Related]
14. The combination of IFN-alpha2 and IFN-alpha8 exhibits synergistic antiproliferative activity on renal cell carcinoma (RCC) cell lines through increased binding affinity for IFNAR-2.
Tanimoto T; Yamamoto S; Taniai M; Taniguchi M; Ariyasu H; Ushio C; Aga M; Mukai Y; Tsutsumi Y; Ariyasu T; Ohta T; Fukuda S
J Interferon Cytokine Res; 2007 Jun; 27(6):517-23. PubMed ID: 17572016
[TBL] [Abstract][Full Text] [Related]
15. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
[TBL] [Abstract][Full Text] [Related]
16. Structure-function study of the extracellular domain of the human type I interferon receptor (IFNAR)-1 subunit.
Kumaran J; Colamonici OR; Fish EN
J Interferon Cytokine Res; 2000 May; 20(5):479-85. PubMed ID: 10841076
[TBL] [Abstract][Full Text] [Related]
17. A structural basis for interferon-alpha-receptor interactions.
Kumaran J; Wei L; Kotra LP; Fish EN
FASEB J; 2007 Oct; 21(12):3288-96. PubMed ID: 17517919
[TBL] [Abstract][Full Text] [Related]
18. The Atlantic salmon protein tyrosine kinase Tyk2: molecular cloning, modulation of expression and function.
Sobhkhez M; Hansen T; Iliev DB; Skjesol A; Jørgensen JB
Dev Comp Immunol; 2013 Dec; 41(4):553-63. PubMed ID: 23872231
[TBL] [Abstract][Full Text] [Related]
19. Requirement of catalytically active Tyk2 and accessory signals for the induction of TRAIL mRNA by IFN-beta.
Rani MR; Pandalai S; Shrock J; Almasan A; Ransohoff RM
J Interferon Cytokine Res; 2007 Sep; 27(9):767-79. PubMed ID: 17892398
[TBL] [Abstract][Full Text] [Related]
20. Contributions of cloned type I interferon receptor subunits to differential ligand binding.
Cutrone EC; Langer JA
FEBS Lett; 1997 Mar; 404(2-3):197-202. PubMed ID: 9119063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
